Scientists identify potential new drug for inherited cancer
The new study showed the drug candidate — known as FRAX97 — slowed the proliferation and progression of tumor cells in animal models of Neurofibromatosis type 2. This inherited type of cancer, caused by mutations in the anti-tumor gene NF2, leads to tumors of the auditory nerve that connects the inner ear to the brain…